| Formulary Chapter 6: Endocrine system - Full Chapter
|
| 06.02 |
Thyroid and Antithyroid drugs |
|
|
| 06.02.01 |
Thyroid hormones |
|
|
| 06.02.02 |
Antithyroid drugs |
|
|
Carbimazole
|
Formulary
|
Counselling: warn patient to tell doctor immediately if sore throat, mouth ulcers, bruising, fever, malaise or non-specific illness develops
|
Alendronic Acid
(Oral solution)
|
Non Formulary
|
Removed from formulary in Decemeber 2016, replaced by effervescent tablets |
Alendronic Acid (Fosamax®)
|
Non Formulary
|
|
Alendronic Acid (Fosamax® Once Weekly)
|
Non Formulary
|
|
Alendronic Acid with colecalciferol (Fosavance®)
|
Non Formulary
|
|
Disodium Eitdronate (Didronel PMO®)
|
Non Formulary
|
|
Levothyroxine
|
Non Formulary
|
- Eltroxin
- Capsule
- Oral solution
|
Risedronate Sodium (Actonel®)
|
Non Formulary
|
Actonel - Black
RISEDRONATE/CALCIUM CARBONATE/COLECALCIFEROL - Black
RISEDRONATE/CALCIUM CARBONATE/COLECALCIFEROL / Actonel Combi - Black
|
Tiludronic Acid (Skelid®)
|
Non Formulary
|
|
Key |
 |
Restricted Drug |
 |
Unlicensed |
|
|
Link to adult BNF
|
|
|
Link to children's BNF
|
|
|
Link to SPCs
|
|
Cytotoxic Drug |
|
Controlled Drug |
|
|
High Cost Medicine |
|
Cancer Drugs Fund |
|
NHS England |
|
Homecare |
|
ICB |
|
Low carbon footprint |
|
Medium carbon footprint |
|
High carbon footprint |
|
| Status |
Description |
|
Medicines which are suitable for initiation and maintenance prescribing by primary and secondary care clinicians. These medicines should be initiated and prescribed within their licensed indications |
|
Amber Specialist Initiation: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate. This may be supported by a RICaD, annotated within the formulary entry. |
|
Amber Shared Care: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing, in accordance with an ESCA, annotated within the formulary entry. |
|
Amber Specialist Recommendation: Initiation and maintenance of prescribing in Primary Care following recommendation from a specialist. |
|
Medicines for initiation and maintenance prescribing by Specialists (hospital or GPs with Special Interest) only |
|
Positive NICE TA and /or awaiting local clarification on place in therapy; Please contact your Medicines Optimisation team for more information. |
|
Non-formulary Medicines which APC/Trust DTC has actively reviewed and do not recommend for use. |
|
Check Notes as varies across the area |
|
|
